December 6, 2021
The University of Cincinnati's Dr. Mohamed Kamel was featured in a Giddy article explaining reasons why PSA levels may be elevated other than prostate cancer.
November 17, 2021
University of Cincinnati's Dr. Robert Van Haren was featured in a Scientific American article discussing how the pause in lung cancer screening affected patients during the COVID-19 pandemic.
March 9, 2022
Inside Precision Medicine featured recent University of Cincinnati research led by Dr. Trisha Wise-Draper showing adding immunotherapy to standard of care treatments for head and neck cancer increased survival rates for intermediate risk patients.
March 3, 2022
Forbes featured the University of Cincinnati and Cincinnati Children's Hospital Medical Center's John Pestian in a story about the collaborative effort to use supercomputing and AI to help predict and prevent mental illness.
March 15, 2022
55KRC featured University of Cincinnati researcher Jiajie Diao on the Simply Medicine program to discuss advances in a new probe and imaging technique to get a better view of human cells.
May 19, 2022
Local 12 highlighted the University of Cincinnati's Christopher T. Richards and the UC Health mobile stroke unit, which has been dispatched more than 1,100 times since launching in August 2020.
May 10, 2022
The University of Cincinnati's Mladen golubic and Sian Cotton were featured on WVXU's Cincinnati Edition to discuss non-pharmacological approaches to pain management and an upcoming symposium.
September 29, 2022
Laser Focus World's Photonics Hot List highlighted the recent work of the University of Cincinnati's Jiajie Diao, PhD, who published research demonstrating a technique that uses light to help naturally balance mitochondria within cells.
June 13, 2022
University of Cincinnati professors and radiologists Ann Brown and Mary Mahoney joined patient advocate Michele Young and state legislators to celebrate the passage of House Bill 371, a bill that will require insurance companies to cover additional breast cancer screenings.
September 15, 2022
HealthDay highlighted recent University of Cincinnati research that found administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.